Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.500
+0.120 (5.04%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Sonoma Pharmaceuticals Revenue
Sonoma Pharmaceuticals had revenue of $4.35M in the quarter ending December 31, 2025, with 22.03% growth. This brings the company's revenue in the last twelve months to $17.72M, up 26.83% year-over-year. In the fiscal year ending March 31, 2025, Sonoma Pharmaceuticals had annual revenue of $14.29M with 12.19% growth.
Revenue (ttm)
$17.72M
Revenue Growth
+26.83%
P/S Ratio
0.24
Revenue / Employee
$2,215,250
Employees
8
Market Cap
4.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 14.29M | 1.55M | 12.19% |
| Mar 31, 2024 | 12.74M | -537.00K | -4.05% |
| Mar 31, 2023 | 13.27M | 644.00K | 5.10% |
| Mar 31, 2022 | 12.63M | -6.00M | -32.21% |
| Mar 31, 2021 | 18.63M | 701.00K | 3.91% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IM Cannabis | 37.61M |
| Sunshine Biopharma | 37.32M |
| cbdMD | 19.09M |
| RedHill Biopharma | 9.55M |
| InMed Pharmaceuticals | 4.51M |
| China Pharma Holdings | 4.05M |
| China SXT Pharmaceuticals | 1.54M |
| Akanda | 836.66K |
SNOA News
- 27 days ago - Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results - Accesswire
- 5 weeks ago - Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development - Accesswire
- 4 months ago - National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced - Accesswire
- 4 months ago - Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf - Accesswire
- 4 months ago - Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results - Accesswire
- 5 months ago - Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals - Accesswire
- 5 months ago - Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA - Accesswire
- 5 months ago - Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 - Accesswire